Diffuse mesenterial sclerosis: a characteristic feature of chronic small-bowel allograft rejection.
Chronic rejection is the major cause of late intestinal allograft dysfunction. The aim of this study was to analyze in detail the histopathological features of chronic rejection in the ACI-to-Lewis rat model of intestinal transplantation. Chronic rejection was achieved in orthotopic small-bowel allografts (ACI-Lewis) by limited immunosuppression with cyclosporin A (CyA). Isogeneic transplants (ACI-ACI) as well as native bowels (ACI) with and without immunosuppression served as controls. Bowels were removed together with the mesenteries 90 days postoperatively and analyzed using sections stained with hematoxylin and eosin as well as Masson's trichrome. The slides were coded, randomized and analyzed by grading of histological abnormalities. The most striking alterations of the allografts were noticed in the mesenteries exhibiting an extensive infiltration by mononuclear cells accompanied by a progressive diffuse fibrosis with shrinking of the mesenteries. These changes were most pronounced in the perivascular areas of the mesenteric arteriae and venae rectae. Three of five allografts showed vasculitis with myointimal proliferation of the arteriae rectae. Focally, there was spill-over of the inflammatory cells onto the intestinal muscularis propria. The mucosa of the allografts showed mild blunting, lymphocytic infiltration of the crypt epithelium and increased crypt cell apoptoses. The submucosa was unaffected, and there were no detectable abnormalities of the enteric ganglion cells. The present data support the view that chronic rejection of intestinal allografts is characterized by a diffuse sclerosing mesenteritis which may significantly contribute to late graft dysfunction. The present model may be useful to study the pathomechanisms of this inflammatory fibrosing process.
Klaus
Alexander
A
Department of General Surgery, University of Innsbruck, Innsbruck, Austria.
Margreiter
Raimund
R
Pernthaler
Heinz
H
Klima
Günther
G
Offner
Felix A
FA
D000818:Animals; D001808:Blood Vessels / Q000473:pathology; D001835:Body Weight; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D004195:Disease Models, Animal; D006084:Graft Rejection / Q000188:drug therapy / Q000473:pathology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007413:Intestinal Mucosa / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology* / Q000637:transplantation*; D007963:Leukocytes, Mononuclear / Q000473:pathology; D008297:Male; D008643:Mesentery / Q000098:blood supply / Q000473:pathology*; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D012598:Sclerosis / Q000473:pathology; D013997:Time Factors; D014184:Transplantation, Homologous; D014657:Vasculitis / Q000473:pathology
D007166:Immunosuppressive Agents; D016572:Cyclosporine